Industrialized Production of Human iPSC-Derived Cardiomyocytes for Use in Drug Discovery and Toxicity Testing.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Subject Terms:
    • Abstract:
      The article focuses on the use of the induced pluripotent stem cells (iPSCs) in the drug discovery and toxicity testing in the U.S. The intrinsic ability of the iPSCs makes it a flexible cell-based research tool. The iPSC-derived human cardiomyocytes has been observed to process the same genes, proteins, electrophysiological properties and responses to cytotoxic substances.